Attractions for Korean companies in the Global Lung Cancer Surgery and Nutritional Supplements market in 2019-2021
The incidence of lung cancer is highest in Asia and hence globally APAC becomes one of the most attractive markets in 2019. Lung cancer surgery is one of the trusted method used by oncologist in the early stages of cancer and where ever and whenever permissible (in advanced cancer). Lobectomy and Segmentectomy has the highest market share in the lung cancer market globally. The global market of lung cancer surgery is expected to reach 17.38 Billion USD in 2025, while growing at the CAGR of 6.28% between 2019-2025.
While robotic assisted surgery is still at a slow and growing stage, Video Assisted surgery is expected to grow at 3.99% CAGR in the next 7 years. The report also looks at the differential cost of therapy and surgery in major markets such as USA, Australia, Russia, UK, China and India and compares the differential pattern. Post operation, nutritional supplement plays a major role in the well being and recovery of the patients. Companies such as Abbott, Nestle, and few others cover the 70% of market share and are market leaders in cancer nutritional supplements in lung cancer segment. The report also looks at the nutritional market growth and suggests opportunity for it’s readers in the global market.
While robotic assisted surgery is still at a slow and growing stage, Video Assisted surgery is expected to grow at 3.99% CAGR in the next 7 years. The report also looks at the differential cost of therapy and surgery in major markets such as USA, Australia, Russia, UK, China and India and compares the differential pattern. Post operation, nutritional supplement plays a major role in the well being and recovery of the patients. Companies such as Abbott, Nestle, and few others cover the 70% of market share and are market leaders in cancer nutritional supplements in lung cancer segment. The report also looks at the nutritional market growth and suggests opportunity for it’s readers in the global market.
1. ASSUMPTIONS FOR PRIMARY/SECONDARY RESEARCH
2. CURRENCY EXCHANGE RATES
3. ABBREVIATIONS
4. INTRODUCTION – LUNG CANCER MARKET
a. Recent Trends
b. Epidemiology
c. Top 10 Hospitals
d. Demand and Supply Gaps
5. DRIVERS AND RESTRAINTS
6. SWOT ANALYSIS
7. REGULATIONS IN THE LUNG CANCER MARKET
8. SEGMENTATION OF THE LUNG CANCER SURGERY MARKET
a. By Stage of Lung Cancer (SCLC, NSCLC)
b. By Surgical Procedures (Lobectomy, Wedges, etc)
c. By Advanced Surgical Methods (VATS, RATS, Others)
9. SEGMENTATION OF THE LUNG CANCER NUTRITION MARKET
a. By Type of Feed (Tube and Oral Feed)
b. By end user
10. OPPORTUNITY ANALYSIS BY REGION
a. By North American Lung Cancer Market (USA and Canada)
b. By Western Europe Lung Cancer Market (UK, Germany and France)
c. By Asia pacific Lung Cancer Market (China, Japan, India)
d. By Rest of the World (Middle east and ROW)
11. COMPETITION IN LUNG CANCER MARKET - GLOBAL
12. KEY RECOMMENDATIONS
13. APPENDIX
2. CURRENCY EXCHANGE RATES
3. ABBREVIATIONS
4. INTRODUCTION – LUNG CANCER MARKET
a. Recent Trends
b. Epidemiology
c. Top 10 Hospitals
d. Demand and Supply Gaps
5. DRIVERS AND RESTRAINTS
6. SWOT ANALYSIS
7. REGULATIONS IN THE LUNG CANCER MARKET
8. SEGMENTATION OF THE LUNG CANCER SURGERY MARKET
a. By Stage of Lung Cancer (SCLC, NSCLC)
b. By Surgical Procedures (Lobectomy, Wedges, etc)
c. By Advanced Surgical Methods (VATS, RATS, Others)
9. SEGMENTATION OF THE LUNG CANCER NUTRITION MARKET
a. By Type of Feed (Tube and Oral Feed)
b. By end user
10. OPPORTUNITY ANALYSIS BY REGION
a. By North American Lung Cancer Market (USA and Canada)
b. By Western Europe Lung Cancer Market (UK, Germany and France)
c. By Asia pacific Lung Cancer Market (China, Japan, India)
d. By Rest of the World (Middle east and ROW)
11. COMPETITION IN LUNG CANCER MARKET - GLOBAL
12. KEY RECOMMENDATIONS
13. APPENDIX
